Keywords: mgi, pharma, submits, snda, salagen, submitted, supplemental

MGI Pharma Submits sNDA For Salagen

Article | 17 February 1997

Print This

- MGI Pharma has submitted a supplemental New Drug Application tothe US Food and Drug Administration for Salagen tablets (pilocarpine). It ...

Enjoying this article? To continue reading you need to login or subscribe.

Subscribe now
for unlimited access to all articles

Subscriptions are £60 per month, pay as you go.
Find out more details.

Already a subscriber? Click here to log in